United States · FDA National Drug Code directory
Migraine Relief
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72036-305_5852c203-9a31-ece7-e063-6394a90a99d1
- Product NDC
- 72036-305
- Form
- TABLET
- Composition / generic term
- ACETAMINOPHEN, ASPIRIN and CAFFEINE
- Labeler
- HARRIS TEETER
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230830
- Source listing expiry
- 20271231
Source-listed ingredients
- ACETAMINOPHEN — 250 mg/1
- ASPIRIN — 250 mg/1
- CAFFEINE — 65 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (72036-305-03) / 100 TABLET in 1 BOTTLE, PLASTIC · 72036-305-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →